Shankar Balasubramanian
Fondateur chez Biomodal Ltd.
Profil
Shankar Balasubramanian is the founder of Biomodal Ltd.
(founded in 2012) and holds the title of Director.
Mr. Balasubramanian is also the founder of Solexa, Inc. Mr. Balasubramanian's current jobs include being a Director at Bluecat IP Ltd., a Director at Inflex Ltd., a Professor at the University of Cambridge, and a Founding Partner at Ahren Innovation Capital LLP.
Postes actifs de Shankar Balasubramanian
| Sociétés | Poste | Début |
|---|---|---|
Biomodal Ltd.
 Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | Fondateur | 01/01/2012 |
| University of Cambridge | Corporate Officer/Principal | - |
| Bluecat IP Ltd. | Directeur/Membre du Conseil | - |
| Inflex Ltd. | Directeur/Membre du Conseil | - |
Ahren Innovation Capital LLP
 Ahren Innovation Capital LLP Investment ManagersFinance Ahren Innovation Capital LLP (Ahren) is a venture capital firm founded in 2017 by Alice Newcombe-Ellis. The firm is headquartered in Cambridge, UK. | Private Equity Investor | - |
Anciens postes connus de Shankar Balasubramanian
| Sociétés | Poste | Fin |
|---|---|---|
Solexa, Inc.
 Solexa, Inc. Pharmaceuticals: OtherHealth Technology Solexa, Inc. used to create DNA cloning and analyses technologies to enhance gene discovery. It also used to provide genomics, genetics and proteomics technologies to assist the customers in the field of pharmaceutical and agriculture. The company was located in Hayward, CA. | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Solexa, Inc.
Solexa, Inc. Pharmaceuticals: OtherHealth Technology Solexa, Inc. used to create DNA cloning and analyses technologies to enhance gene discovery. It also used to provide genomics, genetics and proteomics technologies to assist the customers in the field of pharmaceutical and agriculture. The company was located in Hayward, CA. | Health Technology |
Biomodal Ltd.
Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Ahren Innovation Capital LLP
Ahren Innovation Capital LLP Investment ManagersFinance Ahren Innovation Capital LLP (Ahren) is a venture capital firm founded in 2017 by Alice Newcombe-Ellis. The firm is headquartered in Cambridge, UK. | Finance |
| Bluecat IP Ltd. | |
| Inflex Ltd. |
